Phase 1 Trial | NI006 shows potential for cardiac amyloid depletion in transthyretin amyloid cardiomyopathy

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial – TCTMD

Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid – American College of cardiology